1 year return (CAGR)
15.33%
Biomarin Pharmaceutical Inc Exchange (NASDAQ, USD)
BMRN
62.21
-1.16 (-1.83%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-11.12%
5 year return (CAGR)
-4.24%
10 year return (CAGR)
-4.03%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
12.04B
Price/Sales
3.54
Ent value
16.57B
Price/Book
1.90
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
165.03
PEG
-
Forward P/E
9.51
EPS growth
-50.02%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 63.68 |
| Daily high | 64.00 |
| Daily low | 61.58 |
| Daily Volume | 2.11M |
| All-time high | 149.13 |
| 1y analyst estimate | 91.42 |
| Beta | 0.23 |
| EPS (TTM) | 0.38 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 25 Feb 2026 |
Downside potential
Loading...
Downside potential data
| BMRN | S&P500 | |
| Current price drop from All-time high | -58.28% | -1.29% |
| Highest price drop | -90.58% | -56.47% |
| Date of highest drop | 27 Aug 2002 | 9 Mar 2009 |
| Avg drop from high | -45.65% | -10.68% |
| Avg time to new high | 57 days | 12 days |
| Max time to new high | 2811 days | 1805 days |
News
